drugset
drugset / Trial / NCT01404182

Tolerability and Immunogenicity Study of Fluval AB Influenza Vaccine in Adults and Elderly Persons

NCT01404182 ↗

Phase 4 Completed 121 enrolled Fluart Innovative Vaccine Ltd, Hungary
Non-randomizedSingle-groupOpen-labelPrevention

Summary

The purpose of this study is to determine the immunogenicity and tolerability of Fluval AB trivalent influenza vaccine in adults and elderly people.

Timeline

Start
2011-07
Primary completion
2011-08
Completion
2011-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluval AB Vaccine 15 ug Intramuscular

Indications

influenza